113. |
Liver transplantation for hepatocellular carcinoma. Best Practice and Research in Clinical Gastroenterology 2005 19: 147-160. |
114. |
Fulminant liver failure. Current Treatment Options in Gastroenterology 2005; 8: 503-518. |
115. |
Acalculous cholecystitis, multifocal gastrointestinal infarction and pancreatitis due to Varicella-Zoster virus. Internal Medicine Journal 2005; 35: 69-70. |
116. |
Natural history of primary biliary cirrhosis. Quarterly Journal of Medicine 2005; 98: 331-336. |
117. |
Dietary fiber reduces ammonia levels in patients with cirrhosis. 2005; 41: 219. |
118. |
FDG PET for discrimination between tumour extension and blood thrombus as a cause of portal vein thrombosis in hepatocellular carcinoma: important role in exclusion of transplant candidacy. Clinical Nuclear Medicine 2005; 30: 408-410. |
119. |
Culture-proven small intestinal bacterial overgrowth as a cause of irritable bowel syndrome: response to lactulose but not broad-spectrum antibiotics. Journal of Gastroenterology 2005; 40: 767-770. |
120. |
Transplantation for Fulminant Hepatic Failure. In: Busuttil RW, Klintmalm GB (Eds). Transplantation of the Liver, 2nd Edition, Elsevier Saunders, Philadelphia, 2005: 161-175. |
121. |
Up-regulation of Toll-like receptor expression in chronic hepatitis C: correlation with circulating pro-inflammatory cytokine levels and hepatic necro-inflammatory activity. Hepatology 2005; 42(Suppl): 547A. |
122. |
Prevalence of Human Mouse Mammary Tumour Virus-Like Virus (HMLV) in Australian Breast and Liver Tissue. Proceedings of Tow Research Awards, Sydney, October 2005 |
123. |
Modulation of intestinal flora for the treatment of hepatic encephalopathy in cirrhosis. In: Haussinger D, Kircheis D, Schleiss F (Eds). Hepatic Encephalopathy and Nitrogen Metabolism. Springer, Dordrecht, The Netherlands, 2006; 539-550. |
124. |
Gut flora, bacterial translocation and chronic liver disease. World Journal of Gastroenterology 2006; 12: 1493-1502. |
125. |
Toll-like receptor expression in chronic hepatitis C: correlation with circulating pro-inflammatory cytokine levels and liver injury. Inflammation Research 2006; 55: 279-285. |
126. |
Reduced expression of Toll-like receptor 2 on peripheral monocytes in chronic hepatitis B. Clinical and Vaccine Immunology 2006; 13: 972-974. |
127. |
Bacterial overgrowth as a cause of irritable bowel syndrome. Current Opinion in Gastroenterology 2006; 22: 669-673. |
128. |
The intestinal flora and bacterial infection in cirrhosis. Journal of Hepatology 2006; 45: 744-757. |
129. |
Regulation of Toll-like receptor 2 expression in chronic hepatitis B by the precore protein. Hepatology 2007; 45: 102-110. |